AstraZeneca aims for $80 bln in total revenue by 2030
The Anglo-Swedish drugmaker had reported total revenue of $45.81 billion last year
AstraZeneca’s anti-Covid reveals gives positive effect over disease risk in vulnerable patients
AstraZeneca acquired sipavibart from RQ Bio in May 2022
AstraZeneca withdraws COVID Vaccine worldwide, weeks after admitting its’s rare side effects
The vaccine, developed by AstraZeneca and Oxford University, was produced by the Serum Institute of India as Covishield
AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
Despite these rare occurrences, the pharmaceutical company maintains that extensive clinical trial data and real-world evidence consistently support…
Covishield vaccine may cause rare side effect, AstraZeneca admits in UK court
The pharmaceutical giant has sold the vaccine globally under the brand names Covishield and Vaxzevria among others
Mexico receives shipment of 870,000 doses of COVID-19 vaccine from India
Mexico received a shipment of 870,000 doses of AstraZeneca’s COVID-19 vaccine from India yesterday. The government said that…